FDA Approves Vorasidenib: A New Hope for Glioma Patients
Reading Time: 2 minutesThe FDA recently approved vorasidenib for the treatment of Grade 2 astrocytoma or oligodendroglioma the first approval for targeted therapy for such tumors.
FDA Approves Vorasidenib: A New Hope for Glioma Patients Read More »
Health News and Updates, People Forum